In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics

Anaerobe

Volumn 16, Issue 5, 2010, Pages 493-500

  Grimoud, Julien ^a,b   Durand, Henri ^b   Courtin, Céline ^a,b   Monsan, Pierre ^c   Ouarné, Françoise ^c   Theodorou, Vassilia ^d   Roques, Christine ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b LALLEMAND SAS   (France)

^c INSA   (France)

^d CEMAGREF   (France)

Author keywords

Glucooligosaccharides; Lactic acid bacteria; Prebiotics; Probiotics; Synbiotics

Indexed keywords

DEXTRAN; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL SURVIVAL; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; CAMPYLOBACTER JEJUNI; CANDIDA ALBICANS; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DRUG SCREENING; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FERMENTATION; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; INTESTINE FLUID; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BUCHNERI; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS FARCIMINIS; LACTOBACILLUS HELVETICUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LISTERIA MONOCYTOGENES; NONHUMAN; PEDIOCOCCUS ACIDILACTICI; POLYMERIZATION; PRIORITY JOURNAL; SALMONELLA ENTERICA; STOMACH JUICE; STRAIN DIFFERENCE; STREPTOCOCCUS THERMOPHILUS;

BIFIDOBACTERIUM; FERMENTATION; INTESTINES; LACTOBACILLUS; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS;

BIFIDOBACTERIUM; LACTOBACILLUS FARCIMINIS;

EID: 77957018318     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2010.07.005     Document Type: Article

References (51)

1. Possemiers S., Grootaert C., Vermeiren J., Gross G., Marzorati M., Verstraete W., et al. The intestinal environment in health and disease - recent insights on the potential of intestinal bacteria to influence human health. Curr Pharm Des 2009, 15:2051-2065.
2. Packey C.D., Sartor R.B. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 2009, 22:292-301.
3. Spiller R., Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis 2009.
4. Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009, 15:1546-1558.
5. Penders J., Stobberingh E.E., van den Brandt P.A., Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007, 62:1223-1236.
6. Bergonzelli G.E., Blum S., Brussow H., Corthesy-Theulaz I. Probiotics as a treatment strategy for gastrointestinal diseases?. Digestion 2005, 72:57-68.
7. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995, 125:1401-1412.
8. Teitelbaum J.E., Walker W.A. Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu Rev Nutr 2002, 22:107-138.
9. Ventura M., O'Flaherty S., Claesson M.J., Turroni F., Klaenhammer T.R., van Sinderen D., et al. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat Rev Microbiol 2009, 7:61-71.
10. Gibson G.R. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998, 80:S209-S212.
11. Boucher J., Daviaud D., Simeon-Remaud M., Carpene C., Saulnier-Blache J.S., Monsan P., et al. Effect of non-digestible gluco-oligosaccharides on glucose sensitivity in high fat diet fed mice. J Physiol Biochem 2003, 59:169-173.
12. Rousseau V., Lepargneur J.P., Roques C., Remaud-Simeon M., Paul F. Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms. Anaerobe 2005, 11:145-153.
13. Roberfroid M.B. Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr 1998, 80:S197-S202.
14. Ziemer C.J., Gibson G.R. An overview of probiotics, prebiotics and synbiotics in the functional food concept: perspectives and future strategies. Int Dairy J 1998, 8:473-479.
15. Fujimori S., Gudis K., Mitsui K., Seo T., Yonezawa M., Tanaka S., et al. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 2009, 25:520-525.
16. Liong M.T. Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence. Int J Mol Sci 2008, 9:854-863.
17. Saulnier D.M., Gibson G.R., Kolida S. In vitro effects of selected synbiotics on the human faecal microbiota composition. FEMS Microbiol Ecol 2008, 66:516-527.
18. Vaugien L., Prevots F., Roques C. Bifidobacteria identification based on 16S rRNA and pyruvate kinase partial gene sequence analysis. Anaerobe 2002, 8:341-344.
19. Lopezmunguia A., Pelenc V., Remaud M., Biton J., Michel J.M., Lang C., et al. Production and purification of alternansucrase, a glucosyltransferase from Leuconostoc-mesenteroides Nrrl B-1355, for the synthesis of oligoalternans. Enzyme Microb Technol 1993, 15:77-85.
20. Remaud M., Paul F., Monsan P., Heyraud A., Rinaudo M. Molecular-weight characterization and structural-properties of controlled molecular-weight dextrans synthesized by acceptor reaction using highly purified dextransucrase. J Carbohydr Chem 1991, 10:861-876.
21. Remaud-Simeon M., Lopez-Munguia A., Pelenc V., Paul F., Monsan P. Production and use of glucosyltransferases from Leuconostoc mesenteroides NRRL B-1299 for the synthesis of oligosaccharides containing alpha-(1->2) linkages. Appl Biochem Biotechnol 1994, 44:101-117.
22. Zarate G., Chaia A.P., Gonzalez S., Oliver G. Viability and beta-galactosidase activity of dairy propionibacteria subjected to digestion by artificial gastric and intestinal fluids. J Food Prot 2000, 63:1214-1221.
23. Schillinger U., Lucke F.K. Antibacterial activity of Lactobacillus sake isolated from meat. Appl Environ Microbiol 1989, 55:1901-1906.
24. De Man J.D., Rogosa M., Sharpe M.E. A medium for the cultivation of Lactobacilli. J Appl Bacteriol 1960, 23:130-135.
25. Kalliomaki M., Salminen S., Isolauri E. Positive interactions with the microbiota: probiotics. Adv Exp Med Biol 2008, 635:57-66.
26. Liong M.T., Shah N.P. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J Dairy Sci 2005, 88:55-66.
27. Sanders M.E. Probiotics: considerations for human health. Nutr Rev 2003, 61:91-99.
28. Takahashi N., Xiao J.Z., Miyaji K., Yaeshiima T., Hiramatsu A., Iwatsuki K., et al. Selection of acid tolerant bifidobacteria and evidence for a low-pH-inducible acid tolerance response in Bifidobacterium longum. J Dairy Res 2004, 71:340-345.
29. Charteris W.P., Kelly P.M., Morelli L., Collins J.K. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol 1998, 84:759-768.
30. Isolauri E., Kirjavainen P.V., Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation?. Gut 2002, 50(Suppl. 3). III54-9.
31. Kirpich I.A., Solovieva N.V., Leikhter S.N., Shidakova N.A., Lebedeva O.V., Sidorov P.I., et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 2008, 42:675-682.
32. Heilpern D., Szilagyi A. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics. Rev Recent Clin Trials 2008, 3:167-184.
33. Davis C.D., Milner J.A. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 2009, 20:743-752.
34. Bogovic-Matijasic B., Rogelj I., Nes I.F., Holo H. Isolation and characterization of two bacteriocins of Lactobacillus acidophilus LF221. Appl Microbiol Biotechnol 1998, 49:606-612.
35. Wichienchot S., Prasertsan P., Hongpattarakere T., Gibson G.R., Rastall R.A. In vitro fermentation of mixed linkage glucooligosaccharides produced by Gluconobacter oxydans NCIMB 4943 by the human colonic microflora. Curr Issues Intest Microbiol 2006, 7:7-12.
36. Djouzi Z., Andrieux C., Pelenc V., Somarriba S., Popot F., Paul F., et al. Degradation and fermentation of alpha-gluco-oligosaccharides by bacterial strains from human colon: in vitro and in vivo studies in gnotobiotic rats. J Appl Bacteriol 1995, 79:117-127.
37. van den Broek L.A., Hinz S.W., Beldman G., Vincken J.P., Voragen A.G. Bifidobacterium carbohydrases-their role in breakdown and synthesis of (potential) prebiotics. Mol Nutr Food Res 2008, 52:146-163.
38. Kaplan H., Hutkins R.W. Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria. Appl Environ Microbiol 2000, 66:2682-2684.
39. Palframan R.J., Gibson G.R., Rastall R.A. Carbohydrate preferences of Bifidobacterium species isolated from the human gut. Curr Issues Intest Microbiol 2003, 4:71-75.
40. Rycroft C.E., Jones M.R., Gibson G.R., Rastall R.A. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 2001, 91:878-887.
41. Olano-Martin E., Mountzouris K.C., Gibson G.R., Rastall R.A. In vitro fermentability of dextran, oligodextran and maltodextrin by human gut bacteria. Br J Nutr 2000, 83:247-255.
42. Holt S.M., Teresi J.M., Cote G.L. Influence of alternansucrase-derived oligosaccharides and other carbohydrates on alpha-galactosidase and alpha-glucosidase activity in Bifidobacterium adolescentis. Lett Appl Microbiol 2008, 46:73-79.
43. Sanz M.L., Cote G.L., Gibson G.R., Rastall R.A. Influence of glycosidic linkages and molecular weight on the fermentation of maltose-based oligosaccharides by human gut bacteria. J Agric Food Chem 2006, 54:9779-9784.
44. Petersen A., Heegaard P.M., Pedersen A.L., Andersen J.B., Sorensen R.B., Frokiaer H., et al. Some putative prebiotics increase the severity of Salmonella enterica Serovar Typhimurium infection in mice. BMC Microbiol 2009, 9:245.
45. Lamine F., Eutamene H., Fioramonti J., Bueno L., Theodorou V. Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats. Scand J Gastroenterol 2004, 39:1250-1258.
46. Ait-Belgnaoui A., Eutamene H., Houdeau E., Bueno L., Fioramonti J., Theodorou V. Lactobacillus farciminis treatment attenuates stress-induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats. Neurogastroenterol Motil 2009, 21:567-573. e18-9.
47. Ainsley Reid A., Vuillemard J.C., Britten M., Arcand Y., Farnworth E., Champagne C.P. Microentrapment of probiotic bacteria in a Ca(2+)-induced whey protein gel and effects on their viability in a dynamic gastro-intestinal model. J Microencapsul 2005, 22:603-619.
48. Wang J., Guo Z., Zhang Q., Yan L., Chen W., Liu X.M., et al. Fermentation characteristics and transit tolerance of probiotic Lactobacillus casei Zhang in soymilk and bovine milk during storage. J Dairy Sci 2009, 92:2468-2476.
49. Sharp M.D., McMahon D.J., Broadbent J.R. Comparative evaluation of yogurt and low-fat cheddar cheese as delivery media for probiotic Lactobacillus casei. J Food Sci 2008, 73. M3M3775-M3M3777.
50. Dunne C., O'Mahony L., Murphy L., Thornton G., Morrissey D., O'Halloran S., et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 2001, 73:386S-392S.
51. Collado M.C., Isolauri E., Salminen S. Specific probiotic strains and their combinations counteract adhesion of Enterobacter sakazakii to intestinal mucus. FEMS Microbiol Lett 2008, 285:58-64.